Bacteroides Uniformis Test

Across studies of people who stay lean, keep their livers healthy, and perform better in endurance events, one gut bacterium keeps showing up more often than in everyone else. Bacteroides uniformis (B. uniformis) is a common resident of the human colon, but its relative abundance varies widely from person to person, and higher levels track closely with the metabolic and immune profiles most adults want.

This is not a mainstream clinical test yet. There are no standardized cutpoints, and the research is mostly observational or mechanistic. What a stool measurement of B. uniformis can do is give you an early, exploratory window into how your diet, fiber intake, and gut environment are shifting, often long before changes show up on a liver enzyme panel or a fasting glucose.

Why Researchers Pay Attention to This Bacterium

B. uniformis lives in the colon and ferments the fibers and complex carbohydrates your small intestine cannot digest. In doing so, it produces byproducts (called short chain fatty acids) and other molecules that influence how you absorb fat, regulate blood sugar, and calm inflammation. In one human study of metabolic-associated fatty liver disease (MAFLD, a current name for the most common form of fatty liver), B. uniformis was the single most depleted species compared to healthy controls, and its abundance fell as liver fat rose.

It is also one of the few gut species that lean women on two different continents share at higher levels than their heavier counterparts, and it is enriched in people who respond well to certain cancer immunotherapies. None of this proves that raising B. uniformis will directly make you healthier, but the pattern across metabolic, immune, and performance research is consistent enough that the species is now a leading candidate for next-generation probiotics.

Metabolic and Liver Health

In a case-control study of adults with and without MAFLD, people with fatty liver had sharply lower B. uniformis in stool, and abundance correlated inversely with liver fat and BMI (body mass index, a measure of weight relative to height). A combined signature of gut bacteria and their byproducts identified MAFLD severity with high accuracy (an area under the curve of 0.93, where 1.0 would be perfect classification).

B. uniformis is also depleted in pregnant women with pre-existing type 2 diabetes, and related gut microbiome patterns are more common in people with higher visceral fat (the fat stored around the organs). None of these studies establish cause. They do suggest that when this species is low, your broader metabolic and liver environment may be under more stress than routine labs can detect.

Inflammatory Bowel Disease and Colorectal Cancer

In 54 adults with active ulcerative colitis (a form of inflammatory bowel disease), lower fecal abundance of B. uniformis tracked with more severe disease on both endoscopy and biopsy, with a moderate inverse link (a correlation near minus 0.44, where minus 1.0 would be a perfect opposite relationship). B. uniformis is also reduced in Crohn's disease and colorectal cancer, fitting a broader pattern in which the beneficial, fiber-fermenting species of the colon tend to disappear when the gut is inflamed or developing tumors.

There is one important exception to the pattern of higher equals better. In a Danish cohort of more than 45,000 bloodstream infections, patients whose blood cultures grew B. uniformis or related anaerobes had a dramatically elevated risk of being diagnosed with colorectal cancer within a year (about 5.4% versus 0.4% with negative cultures). The takeaway: B. uniformis belongs in your gut, not your blood. Finding it in a blood culture is a red flag that the intestinal barrier has been breached, often by an undiagnosed colon lesion.

Reconciling the Apparent Contradiction

So which is it: is more B. uniformis good or bad? The answer depends entirely on where it is. Higher B. uniformis in the stool of a healthy person reflects a well-fed, fiber-rich gut environment and tracks with favorable metabolic and immune profiles. B. uniformis showing up in the bloodstream is an entirely different event that reflects a breach of the gut wall in an acutely ill person. A stool test of this species in someone without an active bloodstream infection is measuring the first situation, not the second.

Exercise and Endurance

In a study of 25 healthy male runners, men with higher fecal B. uniformis completed a 3,000 meter race faster than men with lower levels. When researchers gave some of the men the bacterium's preferred dietary fiber (a type called alpha-cyclodextrin), their endurance improved in a randomized trial. In animal experiments, directly feeding B. uniformis improved endurance by boosting the liver's ability to produce glucose during exercise, though this has not been directly replicated with B. uniformis supplementation in humans.

Research-Reported Levels

This is a Tier 3 research marker. There are no consensus cutpoints, no clinical guidelines, and no universally agreed optimal range. Labs report B. uniformis as a relative abundance (the percentage of your total gut bacteria it represents) from sequencing-based microbiome tests. Different labs use different sequencing methods, so the raw numbers are not directly comparable between tests.

In longitudinal research, B. uniformis is present in essentially all healthy adults and tends to be stable within the same person over time. What is clinically informative is not a fixed number but how your value compares with your own prior results, and whether you are trending up or down relative to your own baseline. Treat any single percentile from a lab report as orientation, not a target.

What this means for you: if your B. uniformis comes back in a low percentile relative to the lab's reference distribution, treat it as one data point in a larger picture, not a verdict. The species is most useful as a trend line, especially when combined with other gut markers and traditional metabolic labs.

When Results Can Be Misleading

Stool-based microbiome results are sensitive to several short-term factors that can shift numbers without reflecting a true change in your gut ecosystem.

• Recent antibiotics: any antibiotic within the prior three to six months can reshape the gut community in ways that take time to recover. A single reading just after antibiotics is often unrepresentative.
• Recent dietary extremes: sharp swings in fiber intake, fasting, or a radically different eating pattern in the 72 hours before collection can shift relative abundances. A sample taken during a week of travel eating is not a fair reflection of your usual state.
• Collection and storage technique: stool that sits at room temperature for too long, or that is collected incorrectly, can distort the relative abundance read by sequencing. Follow the kit's instructions exactly.
• Common medications: proton pump inhibitors, metformin, and some other widely used drugs are known to reshape the gut microbiome broadly. They may shift your B. uniformis reading without indicating disease.

Tracking Your Trend

A single microbiome reading is a snapshot of one day's ecosystem. What matters more is the direction. Because B. uniformis tends to be stable within a person, a clear, sustained drop from your own baseline is more informative than one high or low value in isolation. Serial testing lets you answer the question that a single number cannot: is my gut environment trending in the direction I want?

A reasonable cadence: get a baseline, then retest in three to six months if you are actively changing your diet, adding fiber, or recovering from antibiotics. Once you have established a personal range, annual retesting is enough to catch meaningful drift. If you are using this as part of a specific intervention (more fiber, a different fermented food routine, a new probiotic), testing at three months gives you enough time for a real shift to register.

What to Do With an Abnormal Result

A low B. uniformis result is not a diagnosis. It is a signal that your gut environment may not be as resilient as you want, especially if it sits alongside other findings. Consider pairing this test with a broader gut panel that looks at total microbial diversity, short chain fatty acid production, and markers of gut inflammation. If you also have fatty liver changes on imaging or liver enzymes, elevated fasting insulin, or active digestive symptoms, a low B. uniformis reading strengthens the case to act on the broader pattern rather than wait.

If your result is unexpectedly low and you cannot explain it by recent antibiotics, a major diet change, or a medication effect, a follow-up test in three months is reasonable before changing anything. If digestive symptoms, unintended weight changes, or signs of inflammation are also present, that is worth a gastroenterology workup regardless of what the microbiome shows.